Join to view full profile
551 Brevard RdAsheville, NC 28806
Dr. Wendling is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Stanford Health CareFellowship, Blood & Bone Marrow Transplant, 2009 - 2010
Louisiana State University School of MedicineFellowship, Hematology and Medical Oncology, 2006 - 2009
Creighton University School of Medicine (Omaha)Residency, Internal Medicine, 1997 - 2000
LSU School of Medicine in ShreveportClass of 1997
Certifications & Licensure
CA State Medical License 2008 - Present
LA State Medical License 2005 - 2027
NC State Medical License 2018 - 2027
AR State Medical License 2002 - 2006
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
National Board of Physicians and Surgeons Hematology
National Board of Physicians and Surgeons Internal Medicine
National Board of Physicians and Surgeons Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014, 2016
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Pentostatin, Cyclophosphamide, and Rituximab Followed By Campath-1H in Patients With Relapsed or Refractory B-Cell CLL Start of enrollment: 2005 Apr 14
Publications & Presentations
Abstracts/Posters
- Saftey of Total Therapy II with or without Thalidomide for Newly Diagnosed Myeloma: A study of 475 consecutive patientsAnaissie, E., Jacobson, J., Fassas, A.,Zangari, M., Thertulien, R., Van Rhee, F., Talamo, G., Tricot, G., Wendling, C., Davis, C., Holmig, K., and Barlogie, B., Abstract#1675 Blood, Volume 102, Issue 11
- Absence of Hypodiploidy and/or Chromosome 13 Abnormalities (hypo-CA 13) Confers Superior Survival in Multiple Myeloma PatientsFassas, A.,Sawyer, J., McCoy, J., Anaissie, E., Lee, C.K., Talamo, G., Wendling, C., Zangari, M., Van Rhee, F., Thertulien, R., Tricot, G., and Barlogie, B., Abstract #2534 Blood, Volume 102 Issue 11
- Effect of dose of melphalan used in conditioning regimen on outcomes of autologous stem cell transplantation in overweight/obese patients with multiple myeloma.Elizabeth Ellent, Sachin Gopalkrishn Pai, Ashley Chasick, Qingyang Luo, Charles V. Wendling, Robert Emmons, Journal of Clinical Oncology, Ochsner Medical Center, New Orleans, LA, 2015
Press Mentions
American Oncology Network : Messino Cancer Centers Strengthens Commitment to Patient Care with New PhysicianJune 4th, 2024
Professional Memberships
- Member
- Member
- American Society for Transplantation and Cellular Therapy - ASTCTMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
